ArticlePeerJ2026
Characteristics and outcome of rhabdomyolysis in acute ischemic stroke patients: a 10-year retrospective study.
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: While acute ischemic stroke (AIS) and rhabdomyolysis (RML) have been reported to co-occur, their clinical relationship and associated outcomes remain poorly understood. This study aimed to investigate the clinical characteristics and outcomes of patients with concurrent AIS and RML. Methods: A retrospective analysis was conducted on patients admitted to the Department of Neurology from January 2014 to December 2023. The clinical and laboratory indicators, as well as the prognosis at discharge, were assessed. Results: Among 9,360 AIS patients, 146 with RML (CK > 1,000 U/L) were assigned to the RML group, while 146 without RML formed the control group. Patients with RML had a higher incidence of comorbidities and acute complications, including diabetes (43.15% Conclusions: AIS patients with RML exhibited an increased poor outcome rate. While multivariable analysis identified NIHSS score >15, infection, and elevated troponin I as independent predictors, RML was not an independent risk factor. Given the observational design and the co-occurrence with severity markers, these associations should not be interpreted as independent effects of RML. These findings pertain to in-hospital outcomes only. Post-discharge functional endpoints (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.